The only trial-tested way to keep weight off after Zepbound is to keep taking it. In SURMOUNT-4, adults who stopped after 36 weeks regained 14.0% of body weight in a year, even with lifestyle counseling, while those who continued lost 5.5% more. If you stop anyway, the tools are the ones in the label's indication: a reduced-calorie diet, more physical activity, and follow-up with a plan to restart if needed. No trial has tested a specific off-drug protocol. If you are new to the drug, start with our tirzepatide guide.
Key takeaways
- SURMOUNT-4: continued tirzepatide, a further -5.5% over 52 weeks; switched to placebo, +14.0%. Both groups received lifestyle counseling.
- The label sets no maximum treatment duration. Zepbound is approved for chronic weight management, and the maintenance doses are 5, 10 and 15 mg.
- No trial in the Sources tested a step-down dose, a stretched interval, or a specific diet after stopping. Any page quoting a regain percentage for those is guessing.
- Weight gain after Zepbound is expected in the data. It is a signal to talk to your prescriber, not a verdict on you.
- Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound; the same maintenance logic applies.
What happens to weight after Zepbound: SURMOUNT-4
SURMOUNT-4 is the trial to know. Adults with obesity took tirzepatide for 36 weeks, escalating to 10 or 15 mg, and lost a mean of 20.9%. Then half continued and half switched to placebo for 52 weeks, with counseling for everyone.
| After week 36 | 52-week change | What it shows |
|---|---|---|
| Continued tirzepatide | -5.5% further | Weight held and kept falling on a maintenance dose |
| Switched to placebo | +14.0% | About two thirds of the loss returned within a year despite counseling |
Source: SURMOUNT-4, Aronne et al., JAMA 2024. "Two thirds" is arithmetic (14.0 divided by 20.9).
The placebo arm is the part people skip. Those participants were not left alone; they had counseling, and they still regained most of the weight. That is why "just eat well and exercise" is not, by itself, a maintenance plan the evidence supports. It is the floor. The full stopping timeline is on what happens when you stop taking tirzepatide.
Why the weight comes back
Tirzepatide reduces appetite and food intake and slows stomach emptying while it is in your body. Its half-life is about 5 days, so it is mostly gone about 25 days after the last dose. When it clears, hunger returns to where it was, meals stop feeling as filling, and intake climbs. The label lists no withdrawal syndrome; the mechanism is simply the drug's effect ending. Nothing about that changes if you lost the weight slowly or quickly.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Option 1: stay on a maintenance dose
The label's maintenance doses are 5, 10 and 15 mg, and there is no maximum duration. The longest trial in the Sources, the SURMOUNT-1 extension, ran 176 weeks with -22.9% at 15 mg and a 94% reduction in progression to type 2 diabetes among adults with prediabetes. Staying on is the choice with data behind it. The open question most people have is whether a lower dose would hold the weight. No trial listed here tested that. If your prescriber is willing to try it, agree on weigh-in frequency and a regain threshold that triggers a review before you change the dose. Details are on tirzepatide maintenance dose after goal weight.
Option 2: stop with a plan
If you are stopping, for cost, side effects, pregnancy plans or preference, the plan should be built on what the label and trials actually support, and it should be honest about what they do not.
| Element | Evidence status | Practical version |
|---|---|---|
| Reduced-calorie diet | Part of the label indication; used in every trial | Keep the eating pattern you built on the drug, especially portion size and meal timing |
| Increased physical activity | Part of the label indication; used in every trial | Keep the routine going before the drug clears, not after regain starts |
| Intensive lifestyle program | SURMOUNT-3 used a 12-week program before tirzepatide; the drug then added -18.4% versus +2.5% on placebo | Structured support helps, but the trial shows it did not replace the drug |
| Regular weigh-ins | Not a trial endpoint; standard follow-up | Weekly, same scale, same time of day |
| Restart threshold | SURMOUNT-4 shows regain is predictable | Agree with your prescriber in advance on a number that triggers a conversation |
| Step-down dose or longer interval | Not tested; not on the label | Prescriber decision only |
Source: Zepbound prescribing information (indication); SURMOUNT-3, Wadden et al., Nat Med 2023; SURMOUNT-4.
We do not print protein grams, training days per week, or a regain percentage for this plan, because no source in our list supplies them for people stopping tirzepatide. The tirzepatide diet plan covers eating patterns without inventing numbers.
Weight gain after Zepbound: what to watch and when to act
Some regain in the first months off the drug is what the data show. The question is trend, not one weigh-in. If weight is climbing steadily toward the threshold you agreed on, that is the time to talk to your prescriber, not after the loss is gone. A restart follows the label's escalation: 2.5 mg once weekly for 4 weeks, then 2.5 mg steps with at least 4 weeks on each. The label's warnings apply from the first dose again, including the boxed warning on thyroid C-cell tumors and the gastrointestinal effects that are most common during escalation.
What this means for compounded tirzepatide
Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate. If cost is why you are stopping Zepbound, know the numbers. Brand vials through LillyDirect run $299 a month at 2.5 mg, $399 at 5 mg, $499 at 7.5 mg and $699 at 10 mg and above; commercial insurance with coverage may bring that to as little as $25 a month with the savings card. At FormBlends, compounded tirzepatide is $149 for the first month, then $239 a month, or $214 a month with Subscribe & Save, at any dose. Longer plans are one-time charges of $627 for 3 months, $1,194 for 6 and $2,148 for 12. See pricing or begin at start.
Frequently Asked Questions
How do I maintain weight loss after Zepbound?
The tested answer is to stay on a maintenance dose; SURMOUNT-4 showed continued loss on the drug and a 14.0% regain off it. If you stop, keep the diet and activity habits, weigh in weekly, and set a restart threshold with your prescriber.
Is weight gain after Zepbound normal?
Yes, in the data. The placebo arm of SURMOUNT-4 regained about two thirds of its loss within a year despite counseling. It reflects the drug's effect ending, not a failure of willpower.
Will a lower Zepbound dose keep the weight off?
No trial in our sources tested it, and the label does not describe it. Some prescribers try it as an individual decision. If yours does, plan the weigh-ins and threshold first.
How fast does weight come back after stopping Zepbound?
SURMOUNT-4 reports the 52-week total, +14.0%, not a month-by-month curve. The drug clears over about 25 days, so appetite returns within the first month and weight follows over the year.
Can I restart Zepbound if I regain?
That is a prescriber decision. A restart follows the label schedule from 2.5 mg, with 4 weeks per step, and the same warnings apply from the start.
Sources
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4), Aronne et al., JAMA, 2024.
- Zepbound (tirzepatide) prescribing information, Eli Lilly via DailyMed, revised 08/2026.
- Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3), Wadden et al., Nature Medicine, 2023.
- Tirzepatide for Obesity Treatment and Diabetes Prevention (SURMOUNT-1 3-year), Jastreboff et al., New England Journal of Medicine, 2025.
- FormBlends pricing, Form Blends LLC, verified September 5, 2026.
Next steps
Read tirzepatide tips for better results for habits that carry over, and tirzepatide maintenance dose after goal weight for the stay-on option. Browse the tirzepatide hub for every other tirzepatide question. Talk to a clinician before you stop or restart. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →